Gilead Sciences CEO Says HIV Prevention Drug Offers Clear Value
Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be…
Stock market news for Aug. 8, 2025
Traders work on the floor at the New York Stock Exchange (NYSE) in New York, US, on Friday,…